HEMATOPOETİK KÖK HÜCRE NAKLİ PROTOKOLLERİ

Kaynaklar:

1- DiPersio JF, Micallef IN, Stiff PJ et al. 2009 "Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma".J Clin Oncol. Oct 1;27(28):4767-73.

2- Jantunen, E., T. Kuittinen, E. Mahlamaki, et al. 2011. "Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experience." Eur J Haematol 86(4):299-304.

3- Costa LJ, Alexander ET, Hogan KR et al. 2010. "Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization". Bone Marrow Transplant. Apr 12

4-Costa LJ, Miller AN, Alexander ET et al. " Growth factor and patient-adapted use of plerixafor is superior to CY and growth factor for autologous hematopoietic stem cells mobilization". Bone Marrow Transplant. 2010 Jul 12.[Epub ahead of print]

5-Milone, G., M. Martino, A. Spadaro, et al. 2014. "Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costs." Br J Haematol 164(1):113-123.

6-DiPersio JF, Stadtmauer EA, Nademanee A et al. 2009 "Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma".Blood. Jun 4;113(23):5720-6

7-Calandra, G., J. McCarty, J. McGuirk, et al. 2008. "AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data." Bone Marrow Transplant 41(4):331-338.

8-Duarte, R. F., B. E. Shaw, P. Marin, et al. 2011. "Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data." Bone Marrow Transplant 46(1):52-58.

9-Micallef, I. N., P. J. Stiff, J. F. DiPersio, et al. 2009. "Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocol." Biol Blood Marrow Transplant 15(12):1578-1586.

10-Malard, F., N. Kroger, I. H. Gabriel, et al. 2012. "Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide." Biol Blood Marrow Transplant 18(2):314-317.